Femtobiomed Inc. (XKON:A327610) announced a private placement of 415,224 convertible redeemable preferred shares at a price of KRW 14,450 per share for gross proceeds of KRW 5,999,986,800 on February 10, 2021. The transaction will include participation from Quad Collaboration Offers One Force Tech PEF for 69,204 shares and Withwin Bio Fund 15 for 346,020 shares. The company issued share at KRW 5,000 par value. The transaction will take place through third party allotment. The convertible redeemable Preferred share can be converted into 415,224 common shares. The initial conversion price is the issue price per share of convertible redeemable preferred stocks conversion price adjustment is the date of calculation, and the weighted arithmetic average stock price for one month retroactive from the date of calculation. The conversion period is from February 27, 2021 to February 26, 2031 The transaction is expected to close on February 26, 2021. The transaction has been approved by board of directors of the company. The Redemption value per share KRW 14, 450.